| Title | The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study. |
| Publication Type | Journal Article |
| Year of Publication | 2014 |
| Authors | Brown, Sheldon T., Janet P. Tate, Tassos C. Kyriakides, Katherine A. Kirkwood, Mark Holodniy, Joseph L. Goulet, Brian J. Angus, William D. Cameron, and Amy C. Justice |
| Corporate Authors | OPTIMA Team |
| Journal | PloS one |
| Volume | 9 |
| Issue | 3 |
| Pagination | e92606 |
| Date Published | 2014 |
| ISSN | 1932-6203 |
| Keywords | Adult, Age Factors, Aged, Biological Markers, Drug Resistance, Multiple, Viral, Follow-Up Studies, HIV Infections, Humans, Male, Middle Aged, Models, Biological, Predictive Value of Tests, Risk Factors |
| Abstract | The VACS Index is highly predictive of all-cause mortality among HIV infected individuals within the first few years of combination antiretroviral therapy (cART). However, its accuracy among highly treatment experienced individuals and its responsiveness to treatment interventions have yet to be evaluated. We compared the accuracy and responsiveness of the VACS Index with a Restricted Index of age and traditional HIV biomarkers among patients enrolled in the OPTIMA study. |
| DOI | 10.1371/journal.pone.0092606 |
| Alternate Journal | PLoS ONE |
